Addressing the Unique Aspects of Psoriasis in Skin of Color
Dr. Amy McMichael discusses psoriasis in skin of color, which she says is more common than many dermatologists think. She shares her approaches to recognizing, diagnosing, and treating psoriasis in darker skin tones. Amy McMichael, MD, Professor of Dermatology, Wake Forest School of Medicine, Winston-Salem, North Carolina “What we found over the years …is that […]
Lasers for Scars in Skin of Color
Dr. DiAnne Davis discusses using lasers safely and effectively to revise scars in skin of color patients, including tips for improving patient outcomes. DiAnne Davis, MD, FAAD, Dermatologist, North Dallas Dermatology Associates, Dallas, Texas “I’m passionate about lasers and energy devices and how far that envelope can be pushed in terms of skin of color […]
JAKs and Biologics for AD in Geriatrics and Peds
Dr. April Armstrong discusses safety and efficacy data for using JAKs and biologics to treat atopic dermatitis in special populations. April Armstrong, MD, Professor of Dermatology, Associate Dean For Clinical Research, Keck School of Medicine, University of Southern California, Los Angeles “When we think about our geriatric patients, this is a very special population because […]
Pigmentation and Papules in the Pediatric SOC Patient
Dr. Patricia Treadwell discusses special considerations in diagnosing and treating skin issues in pediatric patients with darker skin types. Patricia Treadwell, MD, Pediatric Dermatology, Riley Children’s Health, Indiana University Health, Indianapolis, Indiana “[There are] two points that I would make… one is the changes in the pigmentation. Particularly eczema is something where there are pigmentary […]
Literature Lessons – October
Including the latest on acne, atopic dermatitis, COVID-19, cutaneous oncology, drugs and devices, hair and nails, infectious disease, and more. GENERAL DERMATOLOGY A cohort (N=53) of patients with BRACHIORADIAL PRURITUS were treated with medical therapy and/or computed tomography–guided C-spine transforaminal epidural corticosteroid injections. A mean daily dose of gabapentin greater than 1500mg was more often […]
Updates in Pediatric Hyperhidrosis
Dr. Adelaide Hebert discusses the importance of recognizing and treating hyperhidrosis in children with available oral and topical treatment options. Adelaide A. Hebert, MD, FAAD, Professor of Dermatology and Pediatric Dermatology, McGovern Medical School at UTHealth Houston “Because [hyperhidrosis] often starts in the childhood population, I think it’s really important that it’s recognized. It’s very […]
Ted Talks: Health Care Violence
Ted Rosen, MD, FAADEditor-in-Chief I hate doctors. They’ll do anything—anything to keep you coming to them. They’ll sell their souls! What’s worse, they’ll sell yours, and you never know it until you find yourself in hell.” – Eugene O’Neill It was December 18, 1982. An unidentified man walked into the MD Anderson Hospital office of […]
Literature Update: Tattoos and Psoriasis
Dr. Ted Rosen discusses results from a questionnaire-based analysis of 150 tattooed psoriatic patients. Tattoos and Psoriasis: Risk vs. Benefit By Ted Rosen, MD, FAADEditor-in-Chief “Patients with psoriasis are at relatively low but clear risk of complications should they obtain a tattoo. Psoriasis patients have traditionally been cautioned about obtaining a tattoo,” said Ted Rosen, […]
Does Vitamin D3 Benefit PDT Outcomes for Actinic Keratosis?
Drs. Ted Rosen and Neal Bhatia discuss recent study data that suggest patients treated for actinic keratosis who take oral vitamin D3 have an improved response to photodynamic therapy (PDT) treatment. Ted Rosen, MD, FAAD Professor of Dermatology, Baylor College of Medicine, Houston, Texas Neal Bhatia, MD Therapeutics Dermatology, Director, Clinical Dermatology, Therapeutics Clinical Research, […]
New Drugs: Roflumilast Cream 0.3% for Psoriasis
Dr. Ted Rosen details the FDA’s recent approval of roflumilast cream 0.3% for treatment of plaque psoriasis, including intertriginous psoriasis. By Ted Rosen, MD, FAADEditor-in-Chief On July 29, 2022, the FDA approved roflumilast cream 0.3% (Zoryve, Arcutis Biotherapeutics) for the treatment of plaque psoriasis, including intertriginous psoriasis, in adults and adolescents 12 years of age […]